Trial Profile
The efficacy of mirabegron additional therapy for lower urinary tract symptoms after treatment with α1-adrenergic receptor blocker monotherapy: prospective analysis of elderly men
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Oct 2022
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Lower urinary tract symptoms; Overactive bladder
- Focus Therapeutic Use
- 14 Jul 2016 New trial record